Companies

See how salaries can vary from company to company

II-VI Incorporated develops, manufactures, and markets engineered materials, and optoelectronic components and devices worldwide. The company operates in three segments: II-VI Laser Solutions, II-VI Photonics, and II-VI Performance Products. The II-VI Laser Solutions segment offers optical and electro-optical components and materials primarily used in high-power CO2 lasers; fiber-delivered beam delivery systems, and processing tools and direct diode lasers for industrial lasers; direct diode laser modules, sub-systems, and systems; super-hard materials processing laser systems; and compound se... view company details

Belvedere trading is a proprietary trading firm specializing in equity index and commodity derivatives. view company details

Argus is an independent media organisation with more than 1000 staff. It is headquartered in London and has offices in the world's principal commodity trading and production centres. Argus produces price assessments and analysis of international energy and other commodity markets, and offers bespoke consulting services and industry-leading conferences. Companies in 140 countries around the world use Argus data to index physical trade and as benchmarks in financial derivative markets as well as for analysis and planning purposes. Argus was founded in 1970 and is a privately held UK-registered c... view company details

The Law Offices of Jon Jacobs is your local lemon law attorney protecting buyer's rights. We take cars, trucks, boats and RVs. How we differ from other law firms: 1 - We specialize in lemon law. 2 - We don't take retainers! We can get our clients a buyback or refund at no fee to them. The manufacturer pays our attorney fees, so clients don't have to. 3 - Our office is local and personal. 4 - We go after the manufacturer, not the dealer. 5 - We pay special attention to our clients and their needs before our own. We keep the lines of communication open and stay in contact often. view company details

Highland Homes was founded in 1985, with a commitment to provide outstanding design and customer service to our buyers. Family-owned from the beginning, we have grown to become one of the leading single-family homebuilders in the United States. Today, we build over 2,500 homes a year in the Austin, Dallas-Fort Worth, Houston and San Antonio areas. Our growth has not lessened our commitment to our mission statement of "delivering homes we are proud of" and ensuring each Highland homeowner realizes their American dream. While innovative use of space, numerous design touches and our unwavering co... view company details

Thank you for considering our firm for your professional staffing requirements. Established in 2008, Patriot Staffing & Services, LLC is a full service professional placement firm. We source, pre-qualify and present candidates for contract, contract-to-hire and direct-hire placement depending upon our client's requirements. A US Veteran-Owned small business firm, we are proud of those attributes that make us unique: * Our lean operating model allows us to pass savings on to our clients. * Our experience as a buyer of staffing services provides a unique perspective and a sensitivity to our clie... view company details

Cohen & Steers, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides its services to institutional investors, including pension funds, endowments, and foundations. It manages separate client-focused equity, fixed income, multi-asset, and commodity portfolios through its subsidiaries. The firm launches and manages equity, fixed income, balanced, and multi-asset mutual funds through its subsidiaries. Through its subsidiaries, it also launches and manages hedge funds. The firm invests in public equity, fixed income, and commodity markets across th... view company details

TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer and wet age-related macular degeneration (AMD). Its lead product candidate is TRC105, an endoglin antibody, which is in randomized Phase III clinical trial for angiosarcoma; Phase I/II clinical trial for hepatocellular carcinoma; Phase I clinical trial for lung cancer; Phase I/II clinical trial for breast cancer; Phase II clinical trials for prostate cancer; and randomized Phase II clinical trial for wet AMD. The company also develops TRC102, a small molecule t... view company details

Copart, Inc. provides online auctions and vehicle remarketing services. It offers a range of services for processing and selling vehicles over the Internet through its Virtual Bidding Third Generation Internet auction-style sales technology to vehicle sellers, insurance companies, banks and finance companies, charities, and fleet operators and dealers, as well as for individual owners. The company's services include online seller access, salvage estimation, estimating, end-of-life vehicle processing, virtual insured exchange, transportation, vehicle inspection stations, on-demand reporting, mo... view company details

As a car buyer, no one wants a hard sell. You want a shopping experience that is easy and enjoyable. You want to feel confident that you are getting a great price on the new car you want, without the hassle. At Cartelligent, we've leveraged our relationships with dealers and manufacturers to deliver Californians a better way to buy or lease a new car for the past two decades. At Cartelligent, we're changing the way you buy or lease a new car. To learn more, visit our website at cartelligent.com Cartelligent Careers: Every Cartelligent employee is committed to helping our clients drive away hap... view company details

James Capital Advisors, Inc. (JCA) is a commercial real estate brokerage firm that specializes in net lease and multifamily investment sales throughout the U.S. Originally founded by Mike James as "The James Group" in 2012, the firm rebranded to "James Capital Advisors" in 2018 and set out to develop the next generation of real estate brokerage services. In the 18 months that followed, the firm experienced 400% growth and established a new flagship office in Los Angeles, CA. James Capital Advisors operates on a transparency-driven shared client management platform. This allows us to avoid dupl... view company details

Started in the 1970's as a local buyer's club, the Co-op has grown into a Middlebury landmark with over 5,000 active member owners where customers can expect high quality products, exceptional service, and a friendly personable environment. For over 40 years we have been committed to our values of sustainable business practices, growing the local foods movement, and supporting our community. Our ideal candidates will also be committed to these goals and helping us achieve them. Last year we contributed over $50,000 in donations to our local food shelves, non-profits, and discounts to low-incom... view company details

Ruby Tuesday Inc. is an American multinational foodservice retailer that owns, operates, and franchises Ruby Tuesday restaurants. The concept was started in 1972 by Samuel E. (Sandy) Beall III. The corporation was formed in 1996 as a reincorporation of Morrison Restaurants Inc. They are headquartered in Maryville, Tennessee, and have 736 locations worldwide. Their flagship brand is an American American cuisine casual dining restaurant chain with locations in throughout the eastern half of the United States as far west as Dallas, Kansas City and Minneapolis, with its greatest density of loca... view company details

BlackStar Enterprise Group, Inc. focuses on providing merchant banking and finance services to the crypto-equity and distributed ledger technology industries. It intends to offer consulting and regulatory compliance services to crypto-equity companies and blockchain entrepreneurs for securities, tax, and commodity issues. The company was formerly known as BlackStar Energy Group, Inc. and changed its name to BlackStar Enterprise Group, Inc. in September 2016. The company was incorporated in 2007 and is based in Boulder, Colorado. BlackStar Enterprise Group, Inc. is a subsidiary of International... view company details

Epizyme, Inc., a late-stage biopharmaceutical company, discovers, develops, and commercializes novel epigenetic medicines for patients with cancer and other diseases primarily in the United States. The company's lead products candidate is tazemetostat, an inhibitor of the EZH2 histone methyltransferase, which is in the Phase II clinical trial for patients with relapsed or refractory non-hodgkin lymphoma (NHL); Phase II clinical trial for relapsed or refractory patients with mesothelioma characterized by BAP1 loss-of-function; and Phase II clinical trial for adults and Phase I clinical trial fo... view company details

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. The company's lead products consist of four ophthalmology development programs across three targets, including X-linked retinoschisis that is in Phase I/II clinical trials; X-linked retinitis pigmentosa, which is in Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials for the treatment of inherited retinal diseases, as well as a preclinical program in adrenoleukodystrophy, which i... view company details

Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. The company is developing Zygel, a transdermal cannabidiol gel, which is in Phase II clinical trial for treating children and adolescent patients with developmental and epileptic encephalopathies; is in Phase II/III clinical trial to treat children and adolescent patients with fragile X syndrome; and is in Phase II clinical trial for treating children and adolescent pa... view company details

Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing novel therapies for central nervous system (CNS) disorders in the United States. Its product pipeline includes AXS-05, which is in the Phase III clinical trial for the treatment resistant depression; Phase II/III clinical trials in agitation associated with Alzheimer's disease; and Phase II clinical trial for the treatment of smoking cessation, as well as for major depressive disorder. The company is also developing AXS-07, which is in Phase III clinical trial for the treatment of migraine; AXS-12 that... view company details

Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of drugs directed against nuclear transport and related targets for the treatment of cancer and other diseases. Its lead drug candidate is Selinexor(KPT-330), which is in Phase IIb clinical study in treatments of refractory multiple myeloma; Phase Ib/II clinical study in combination with backbone treatments for multiple myeloma patients; Phase III clinical trial in combination with Velcade (bortezomib) and dexamethasone for multiple myeloma patients; Phase IIb cli... view company details

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus (AAV) gene delivery platform. The company's lead product candidate is RGX-314, which is in Phase I/IIa clinical trials for the treatment of wet age-related macular degeneration. It is also developing RGX-121 that is in Phase ... view company details